1. Zaragoza F, Stephensen H, Peschke B, et al. 2-(4-Alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem, 2005, 48: 306–311
2. Nettekoven M H, Roche O. Piperazinyl pyridine derivatives as anti-obesity agents. European Patent Specification, EP 1828134B1, 2008-10-29
3. Cooper J, Duan M, Grimes R, et al. Compounds. US Patent, US 2010/0196321A1, 2010-08-05
4. De Johnge S, Dolusic E, Gao L J, et al. Pyrido(3, 2-D)pyrimidines and pharmaceutical compositions useful for medical treatment. US Patent, US 2008/0004285A1, 2008-01-03
5. Petersen U, Grohe K, Zeiler H J, et al. 1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyll)-3-quinolinecarboxykic acids and antibacterial agents containing them. US Patent, 4.806.539, 1989-02-21